Sale!

FGFR2 Gene Craniofacial Skeletal Dermatologic Dysplasia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The FGFR2 Gene Craniofacial Skeletal Dermatologic Dysplasia NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the FGFR2 gene responsible for complex developmental disorders affecting craniofacial structures, skeletal system, and skin. Using advanced Next-Generation Sequencing (NGS) technology, this test provides precise detection of genetic variants associated with conditions like Apert syndrome, Crouzon syndrome, and Pfeiffer syndrome. The test costs $500 USD and is essential for individuals presenting with craniosynostosis, syndactyly, midface hypoplasia, or dermatologic abnormalities. Results help guide treatment decisions, provide accurate diagnosis, and enable genetic counseling for family planning. With a turnaround time of 3-4 weeks, this test offers valuable insights for patients and healthcare providers managing complex genetic conditions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

FGFR2 Gene Craniofacial Skeletal Dermatologic Dysplasia NGS Genetic DNA Test

Comprehensive Genetic Analysis for Complex Developmental Disorders

The FGFR2 Gene Craniofacial Skeletal Dermatologic Dysplasia NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for complex developmental disorders affecting multiple body systems. This advanced genetic test specifically targets the FGFR2 (Fibroblast Growth Factor Receptor 2) gene, which plays a crucial role in embryonic development, bone formation, and tissue differentiation.

What This Test Measures and Detects

Our comprehensive NGS-based genetic test analyzes the entire FGFR2 gene sequence to identify pathogenic variants, including:

  • Point mutations affecting FGFR2 protein function
  • Insertions and deletions disrupting normal gene expression
  • Missense mutations associated with craniofacial abnormalities
  • Genetic variants linked to skeletal development disorders
  • Mutations causing dermatologic manifestations

Advanced NGS Technology for Precision Diagnosis

Utilizing Next-Generation Sequencing technology, this test provides unparalleled accuracy in detecting FGFR2 gene mutations. The high-throughput sequencing approach ensures comprehensive coverage of the entire gene, enabling identification of both common and rare variants that may contribute to complex developmental syndromes.

Who Should Consider This Genetic Test

This test is recommended for individuals presenting with the following symptoms or clinical features:

  • Craniofacial Abnormalities: Craniosynostosis (premature fusion of skull sutures), midface hypoplasia, hypertelorism, or proptosis
  • Skeletal Manifestations: Syndactyly (fused fingers or toes), limb abnormalities, or vertebral anomalies
  • Dermatologic Features: Acanthosis nigricans, skin texture changes, or abnormal hair patterns
  • Family History: Individuals with family members diagnosed with FGFR2-related syndromes
  • Unexplained Developmental Delays: Children with multiple congenital anomalies affecting craniofacial, skeletal, and dermatologic systems

Clinical Indications for Testing

Healthcare providers typically recommend this test when patients present with features suggestive of FGFR2-related syndromes such as Apert syndrome, Crouzon syndrome, Pfeiffer syndrome, or other craniosynostosis disorders. Early genetic diagnosis can significantly impact treatment planning and management strategies.

Benefits of FGFR2 Genetic Testing

Undergoing FGFR2 genetic testing provides numerous advantages for patients and their families:

  • Accurate Diagnosis: Confirms or rules out FGFR2-related genetic conditions
  • Personalized Treatment Planning: Enables targeted interventions based on specific genetic findings
  • Family Planning Guidance: Provides crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely medical and surgical management
  • Comprehensive Care Coordination: Helps assemble appropriate multidisciplinary care teams
  • Prognostic Information: Offers insights into potential disease progression and outcomes

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your FGFR2 gene analysis:

Positive Result Interpretation

A positive result indicates the presence of a pathogenic FGFR2 gene mutation. This finding confirms the genetic basis of observed clinical features and enables:

  • Specific syndrome diagnosis and classification
  • Targeted management strategies
  • Family member testing recommendations
  • Long-term monitoring planning

Negative Result Interpretation

A negative result suggests no pathogenic FGFR2 mutations were detected. This information helps:

  • Exclude FGFR2-related conditions from differential diagnosis
  • Guide further genetic testing for other potential causes
  • Provide reassurance for family planning decisions

Variant of Uncertain Significance (VUS)

In some cases, the test may identify genetic variants with unclear clinical significance. Our genetic counseling team provides comprehensive guidance on interpreting these findings and recommends appropriate follow-up strategies.

Test Pricing and Details

Test Component Details
Test Name FGFR2 Gene Craniofacial Skeletal Dermatologic Dysplasia NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements and Preparation

To ensure optimal testing outcomes, please note the following pre-test requirements:

  • Clinical History: Comprehensive medical history of the patient undergoing testing
  • Genetic Counseling: Pre-test genetic counseling session to discuss testing implications
  • Family Pedigree: Development of a detailed family pedigree chart documenting affected relatives
  • Informed Consent: Thorough discussion of benefits, limitations, and potential outcomes

Nationwide Availability Across USA

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including:

  • New York City and surrounding areas
  • Los Angeles and Southern California region
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas facilities
  • Phoenix, Arizona testing centers
  • Miami, Florida genetic testing locations
  • And comprehensive coverage throughout all 50 states

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic conditions affect your health decisions. Our FGFR2 genetic testing provides the clarity needed for informed medical management and family planning. With our discounted price of $500 USD and comprehensive genetic analysis, you can access world-class diagnostic services without financial burden.

Ready to Schedule Your Test?

Contact our genetic specialists today to discuss your testing needs and schedule your appointment. Call us at +1(267) 388-9828 or use our convenient online booking system to secure your testing appointment.

Book Your FGFR2 Genetic Test Today – Gain the genetic insights necessary for optimal healthcare decisions and comprehensive family planning. Our team of genetic counselors and medical specialists are ready to support you through every step of the testing process.